151 related articles for article (PubMed ID: 31446969)
21. Gelified Biofluids for High-Resolution Magic Angle Spinning
Takis PG; Tenori L; Ravera E; Luchinat C
Anal Chem; 2017 Jan; 89(2):1054-1058. PubMed ID: 28050906
[TBL] [Abstract][Full Text] [Related]
22. Effect of Repeated Freeze-Thaw Cycles on NMR-Measured Lipoproteins and Metabolites in Biofluids.
Wang F; Debik J; Andreassen T; Euceda LR; Haukaas TH; Cannet C; Schäfer H; Bathen TF; Giskeødegård GF
J Proteome Res; 2019 Oct; 18(10):3681-3688. PubMed ID: 31476120
[TBL] [Abstract][Full Text] [Related]
23. Metabolite patterns predicting sex and age in participants of the Karlsruhe Metabolomics and Nutrition (KarMeN) study.
Rist MJ; Roth A; Frommherz L; Weinert CH; Krüger R; Merz B; Bunzel D; Mack C; Egert B; Bub A; Görling B; Tzvetkova P; Luy B; Hoffmann I; Kulling SE; Watzl B
PLoS One; 2017; 12(8):e0183228. PubMed ID: 28813537
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics of cancer.
Serkova NJ; Glunde K
Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
[TBL] [Abstract][Full Text] [Related]
25. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
26. The application of micro-coil NMR probe technology to metabolomics of urine and serum.
Grimes JH; O'Connell TM
J Biomol NMR; 2011 Apr; 49(3-4):297-305. PubMed ID: 21380855
[TBL] [Abstract][Full Text] [Related]
27. The influence of sample collection methodology and sample preprocessing on the blood metabolic profile.
Jørgenrud B; Jäntti S; Mattila I; Pöhö P; Rønningen KS; Yki-Järvinen H; Orešič M; Hyötyläinen T
Bioanalysis; 2015; 7(8):991-1006. PubMed ID: 25966010
[TBL] [Abstract][Full Text] [Related]
28. Impact of Pre-analytic Blood Sample Collection Factors on Metabolomics.
Townsend MK; Bao Y; Poole EM; Bertrand KA; Kraft P; Wolpin BM; Clish CB; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):823-829. PubMed ID: 26941367
[TBL] [Abstract][Full Text] [Related]
29. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies.
Maher AD; Zirah SF; Holmes E; Nicholson JK
Anal Chem; 2007 Jul; 79(14):5204-11. PubMed ID: 17555297
[TBL] [Abstract][Full Text] [Related]
30. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
31. Determination of amino acids in urine of patients with prostate cancer and benign prostate growth.
Sroka WD; Boughton BA; Reddy P; Roessner U; Słupski P; Jarzemski P; Dąbrowska A; Markuszewski MJ; Marszałł MP
Eur J Cancer Prev; 2017 Mar; 26(2):131-134. PubMed ID: 27222937
[TBL] [Abstract][Full Text] [Related]
32. Independent or integrative processing approach of metabolite datasets from different biospecimens potentially affects metabolic pathway recognition in metabolomics.
Zhou L; Xu JD; Zhou SS; Zhu H; Kong M; Shen H; Zou YT; Cong LJ; Xu J; Li SL
J Chromatogr A; 2019 Feb; 1587():146-154. PubMed ID: 30580960
[TBL] [Abstract][Full Text] [Related]
33. Serum and urine
Wojtowicz W; Zabek A; Deja S; Dawiskiba T; Pawelka D; Glod M; Balcerzak W; Mlynarz P
Sci Rep; 2017 Aug; 7(1):9108. PubMed ID: 28831094
[TBL] [Abstract][Full Text] [Related]
34. Impact of storage conditions on the urinary metabolomics fingerprint.
Laparre J; Kaabia Z; Mooney M; Buckley T; Sherry M; Le Bizec B; Dervilly-Pinel G
Anal Chim Acta; 2017 Jan; 951():99-107. PubMed ID: 27998490
[TBL] [Abstract][Full Text] [Related]
35. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.
Chen DQ; Cao G; Chen H; Liu D; Su W; Yu XY; Vaziri ND; Liu XH; Bai X; Zhang L; Zhao YY
Redox Biol; 2017 Aug; 12():505-521. PubMed ID: 28343144
[TBL] [Abstract][Full Text] [Related]
36. Potential of nuclear magnetic resonance metabolomics in the study of prostate cancer.
Reddy RR; Jagannathan NR
Indian J Urol; 2022; 38(2):99-109. PubMed ID: 35400867
[TBL] [Abstract][Full Text] [Related]
37. Free and total prostate-specific antigen levels in saliva and the comparison with serum levels in men.
Turan T; Demir S; Aybek H; Atahan O; Tuncay OL; Aybek Z
Eur Urol; 2000 Nov; 38(5):550-4. PubMed ID: 11096235
[TBL] [Abstract][Full Text] [Related]
38. Proof of concept for quantitative urine NMR metabolomics pipeline for large-scale epidemiology and genetics.
Tynkkynen T; Wang Q; Ekholm J; Anufrieva O; Ohukainen P; Vepsäläinen J; Männikkö M; Keinänen-Kiukaanniemi S; Holmes MV; Goodwin M; Ring S; Chambers JC; Kooner J; Järvelin MR; Kettunen J; Hill M; Davey Smith G; Ala-Korpela M
Int J Epidemiol; 2019 Jun; 48(3):978-993. PubMed ID: 30689875
[TBL] [Abstract][Full Text] [Related]
39. Collection and Preparation of Clinical Samples for Metabolomics.
Chetwynd AJ; Dunn WB; Rodriguez-Blanco G
Adv Exp Med Biol; 2017; 965():19-44. PubMed ID: 28132175
[TBL] [Abstract][Full Text] [Related]
40. Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review.
Bansal N; Kumar M; Sankhwar SN; Gupta A
Expert Rev Mol Med; 2022 Jun; 24():e25. PubMed ID: 35730322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
